SCHEMBL4922903

SCHEMBL4922903

CCNc1cc(Cl)cc(COc2c(Cl)cc(CC(F)C(=O)O)cc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.39
THRB P10828 2/20 0.39
THRA P10827 1/20 0.39
LMNA P02545 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
PPARA Q07869 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
SLC7A5 Q01650 1/20 0.31
IDO1 P14902 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933984 0.92 FFAR1 (0.39) FFAR1THRBTHRALMNAMRGPRX4
SCHEMBL4931582 0.90 FFAR1 (0.39) FFAR1THRBTHRAMRGPRX4MEN1
SCHEMBL4356850 0.90 THRB (0.50) FFAR1THRBTHRALMNAMAPT
SCHEMBL4933397 0.89 FFAR1 (0.40) FFAR1THRBTHRALMNAMRGPRX4
SCHEMBL4934146 0.87 MME (0.40) FFAR1THRBTHRAMRGPRX4FFAR4
SCHEMBL5119830 0.87 TSHR (0.40) FFAR1THRBTHRALMNAMRGPRX4
SCHEMBL4926575 0.87 FFAR1 (0.39) FFAR1THRBLMNAMRGPRX4MEN1
SCHEMBL5112370 0.87 FFAR1 (0.39) FFAR1LMNAMRGPRX4MEN1KMT2A
SCHEMBL5110942 0.86 FFAR1 (0.37) FFAR1THRBLMNAMRGPRX4MEN1
SCHEMBL4931005 0.86 FFAR1 (0.37) FFAR1THRBLMNAMRGPRX4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA FFAR1 37/4885THRB 4/4885THRA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.